While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.